Injecting support into Unilife

Foster Stockbroking has begun coverage of Unilife with a "buy" recommendation after visiting the company's plant in the US.

More experts are coming around to the upside potential of Unilife Corporation (UNS), with Foster Stockbroking initiating coverage on the stock with a “buy” recommendation following a site visit to its Pennsylvania plant.

Unilife, which is an Uncapped 100 stock, develops one-use pre-filled syringes that have been described by the stockbroker as being a “game-changer” for the injectable devices industry.

{{content.question}}

SMS Code Sent…

Hi {{ user.FirstName }}

Looks like you've already taken a free trial

Please enter your payment details

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

If you didn't receive SMS code please

Looks you are already a member. Please enter your password to proceed

Please untick this box when using a public or shared device


Verify your mobile number

Please sign up for full access

Updating information

Please wait ...

  • Mastercard
  • Visa

Related Articles